608 Q2W
SSGJ-608-PsO-III-01
Phase 3 small_molecule completed
Quick answer
608 Q2W for Psoriasis is a Phase 3 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sunshine Biopharma
- Indication
- Psoriasis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed